JPMORGAN CHASE & CO - 31 Mar 2025 SCHEDULE 13G Report for ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares (ATHE)

Filing Manager
JPMORGAN CHASE & CO
Reporting Manager
JPMORGAN CHASE & CO.
Security
ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares
Symbol
ATHE
Shares outstanding
6,820,182,286 shares
Disclosed Ownership
429,671,484 shares
Ownership
6.3%
Form type
SCHEDULE 13G
Filing time
02 May 2025, 09:59:54 UTC
Date of event
31 Mar 2025
Next filing
05 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"JPMORGAN CHASE & CO disclosed 6.3% ownership in ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares (ATHE) on 31 Mar 2025."

Quick Takeaways

  • JPMORGAN CHASE & CO filed SCHEDULE 13G for ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares (ATHE).
  • Disclosed ownership: 6.3%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 May 2025, 09:59.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JPMORGAN CHASE & CO. 6.3% 429,671,484 429,671,484 0 Rachel Tsvaygoft Vice President

Sponsored